Search research articles
Contact Us
Filters
Showing results (111-120 of 161) with videos related to
Page
of 17
Sort By:
Current Alzheimer Research
|
August 31, 2011
Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients
Tanja Hochstrasser, Daniela Ehrlich, Josef Marksteiner, et al.
Acta Neuropathologica
|
April 12, 2012
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
Nadia Stefanova, Walter A Kaufmann, Christian Humpel, et al.
Journal of Alzheimer'S Disease : JAD
|
March 9, 2017
Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 9, 2016
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment
Kristaps Klavins, Therese Koal, Guido Dallmann, et al.
Experimental Gerontology
|
December 17, 2013
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study
Josef Marksteiner, Douglas Imarhiagbe, Michaela Defrancesco, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
May 1, 2012
Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects
Tanja Hochstrasser, Josef Marksteiner, Michaela Defrancesco, et al.
The European Journal of Neuroscience
|
January 1, 1990
Neuropeptide Levels after Pentylenetetrazol Kindling in the Rat
Josef Marksteiner, Hans Lassmann, Alois Saria, et al.
Frontiers in Bioscience (Landmark Edition)
|
March 28, 2025
Novel Plasma Biomarkers for Alzheimer's Disease: Insights from Organotypic Brain Slice and Microcontact Printing Techniques
Sakir Necat Yilmaz, Katharina Steiner, Josef Marksteiner, et al.
Cardiovascular Psychiatry and Neurology
|
May 29, 2010
S100b counteracts neurodegeneration of rat cholinergic neurons in brain slices after oxygen-glucose deprivation
Daniela Serbinek, Celine Ullrich, Michael Pirchl, et al.
Journal of Neuroscience Methods
|
December 10, 2017
Nerve growth factor released from collagen scaffolds protects axotomized cholinergic neurons of the basal nucleus of Meynert in organotypic brain slices
Bettina M Foidl, Buket Ucar, Alina Schwarz, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 161) with videos related to
Sort By:
Page
of 17
Current Alzheimer Research
|
August 31, 2011
Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients
Tanja Hochstrasser, Daniela Ehrlich, Josef Marksteiner, et al.
Acta Neuropathologica
|
April 12, 2012
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
Nadia Stefanova, Walter A Kaufmann, Christian Humpel, et al.
Journal of Alzheimer'S Disease : JAD
|
March 9, 2017
Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
January 9, 2016
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment
Kristaps Klavins, Therese Koal, Guido Dallmann, et al.
Experimental Gerontology
|
December 17, 2013
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study
Josef Marksteiner, Douglas Imarhiagbe, Michaela Defrancesco, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
May 1, 2012
Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects
Tanja Hochstrasser, Josef Marksteiner, Michaela Defrancesco, et al.
The European Journal of Neuroscience
|
January 1, 1990
Neuropeptide Levels after Pentylenetetrazol Kindling in the Rat
Josef Marksteiner, Hans Lassmann, Alois Saria, et al.
Frontiers in Bioscience (Landmark Edition)
|
March 28, 2025
Novel Plasma Biomarkers for Alzheimer's Disease: Insights from Organotypic Brain Slice and Microcontact Printing Techniques
Sakir Necat Yilmaz, Katharina Steiner, Josef Marksteiner, et al.
Cardiovascular Psychiatry and Neurology
|
May 29, 2010
S100b counteracts neurodegeneration of rat cholinergic neurons in brain slices after oxygen-glucose deprivation
Daniela Serbinek, Celine Ullrich, Michael Pirchl, et al.
Journal of Neuroscience Methods
|
December 10, 2017
Nerve growth factor released from collagen scaffolds protects axotomized cholinergic neurons of the basal nucleus of Meynert in organotypic brain slices
Bettina M Foidl, Buket Ucar, Alina Schwarz, et al.
Page
of 17